Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meinhard Haltmayer

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Cardiology|June 14, 2005
Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failureThomas Mueller, Alfons Gegenhuber, Meinhard Haltmayer
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 2, 2003
Measuring blood homocysteine levels in stroke patientsMeinhard Haltmayer, Thomas Mueller, Werner Poelz
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial diseaseBenjamin Dieplinger, Werner Poelz, Meinhard Haltmayer, et al.
Clinical Chemistry|May 27, 2003
Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart diseaseThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 18, 2004
Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart diseaseThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Chemistry|May 27, 2004
Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assayThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Laboratory|April 13, 2004
Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determinationMeinhard Haltmayer, Thomas Mueller, Alfons Gegenhuber, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 4, 2009
Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) studyBenjamin Dieplinger, Meinhard Haltmayer, Werner Poelz, et al.
Clinical Chemistry|April 15, 2006
Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease StudyThomas Mueller, Benjamin Dieplinger, Werner Poelz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 23, 2006
Association of adiponectin and amino terminal proBNP in peripheral arterial diseaseBenjamin Dieplinger, Werner Poelz, Meinhard Haltmayer, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|June 14, 2005
Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failureThomas Mueller, Alfons Gegenhuber, Meinhard Haltmayer
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 2, 2003
Measuring blood homocysteine levels in stroke patientsMeinhard Haltmayer, Thomas Mueller, Werner Poelz
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial diseaseBenjamin Dieplinger, Werner Poelz, Meinhard Haltmayer, et al.
Clinical Chemistry|May 27, 2003
Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart diseaseThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 18, 2004
Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart diseaseThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Chemistry|May 27, 2004
Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assayThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Laboratory|April 13, 2004
Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determinationMeinhard Haltmayer, Thomas Mueller, Alfons Gegenhuber, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 4, 2009
Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) studyBenjamin Dieplinger, Meinhard Haltmayer, Werner Poelz, et al.
Clinical Chemistry|April 15, 2006
Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease StudyThomas Mueller, Benjamin Dieplinger, Werner Poelz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 23, 2006
Association of adiponectin and amino terminal proBNP in peripheral arterial diseaseBenjamin Dieplinger, Werner Poelz, Meinhard Haltmayer, et al.
Pageof 7